Elizabeth J Ramos- Orosco
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Elizabeth J Ramos- Orosco has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Paolo A. Zegarra-Lizana
School of Medicine, Universidad Peruana de Ciencias Aplicadas, Lima, Peru; Sociedad Científica de Estudiantes de Medicina de la Universidad Peruana de Ciencias Aplicadas, Universidad Peruana de Ciencias Aplicadas, Lima, Peru
2 shared publications - Vicente Aleixandre Benites Zapata
Universidad San Ignacio de Loyola
2 shared publications - Ana Claudia Guersoni
ECPE Department-PPCR Program, Harvard T. H. Chan School of Public Health, Boston, MA 02115, USA
1 shared publication - Ariana Vargas-Ruiz
ECPE Department-PPCR Program, Harvard T. H. Chan School of Public Health, Boston, MA 02115, USA
1 shared publication - Betzi Pantoja-Torres
Instituto Médico de la Mujer, Instituto Médico Metabólico, Lima, Peru
1 shared publication Daniel Cisneros
School of Medicine, Universidad Peruana de Ciencias Aplicadas, Lima, PER
1 shared publication
Latest Publications
- Open Access
- 23 January 2025
- Published by MDPI AG in Brain Sciences
- Vol. 15 (2) , 106
MAGNITUDE: Transcranial Magnetic Stimulation for Treatment-Resistant Obsessive–Compulsive Disorder: A Randomized Sham-Controlled Phase II Trial Protocol
Obsessive–Compulsive Disorder (OCD) is a chronic psychiatric condition with a lifetime prevalence of 2–3%. It significantly burdens quality of life and is associated with substantial economic and disease burdens. Cognitive-behavioral therapy and high-dose selective serotonin reuptake inhibitors are considered the first-line treatments for OCD. Approximately two-thirds of patients with Obsessive–Compulsive Disorder (OCD) exhibit inadequate responses to current standard therapies, thus lacking adequate therapy, resulting in a loss of quality of life and huge economic burdens. Repetitive transcranial stimulation (rTMS) is a non-invasive, safe, and well-tolerated intervention that modulates prefrontal cortical circuits involved in OCD. A previous systematic review explored the therapeutic effects of rTMS applied to the dorsolateral prefrontal cortex (dlPFC) area in patients with treatment-resistant OCD. It showed that the application of high-frequency and low-frequency (LF) rTMS to the dlPFC region yielded controversial post-treatment Y-BOCS (Yale-Brown Obsessive–Compulsive Scale) findings due to factors such as small sample sizes, short-term study durations, and variations in rTMS protocols. Objectives: Thus, we propose a theoretical protocol based on previous findings to assess better the effect of LF rTMS for treatment-resistant OCD patients. Methods: We will recruit patients with moderate to severe OCD and limited response to previous treatments from in- and outpatient clinics. We will use fMRI for precious localization of the right dlPFC and application of 1 Hz stimulation of in total 2000 pulses with three times 40 s inter-train intervals 5 days a week, in 6 consecutive weeks. The primary outcome will be the mean reduction in Y-BOCS at the end of this study. Conclusions: This study highlights rTMS’s potential to reform OCD treatment, accentuate safety, accessibility, clinical integration, and future research foundations.
- 23 January 2025
- Published by MDPI AG in Brain Sciences
- Vol. 15 (2) , 106
Open AccessMAGNITUDE: Transcranial Magnetic Stimulation for Treatment-Resistant Obsessive–Compulsive Disorder: A Randomized Sham-Controlled Phase II Trial Protocol
Obsessive–Compulsive Disorder (OCD) is a chronic psychiatric condition with a lifetime prevalence of 2–3%. It significantly burdens quality of life and is associated with substantial economic and disease burdens. Cognitive-behavioral therapy and high-dose selective serotonin reuptake inhibitors are considered the first-line treatments for OCD. Approximately two-thirds of patients with Obsessive–Compulsive Disorder (OCD) exhibit inadequate responses to current standard therapies, thus lacking adequate therapy, resulting in a loss of quality of life and huge economic burdens. Repetitive transcranial stimulation (rTMS) is a non-invasive, safe, and well-tolerated intervention that modulates prefrontal cortical circuits involved in OCD. A previous systematic review explored the therapeutic effects of rTMS applied to the dorsolateral prefrontal cortex (dlPFC) area in patients with treatment-resistant OCD. It showed that the application of high-frequency and low-frequency (LF) rTMS to the dlPFC region yielded controversial post-treatment Y-BOCS (Yale-Brown Obsessive–Compulsive Scale) findings due to factors such as small sample sizes, short-term study durations, and variations in rTMS protocols. Objectives: Thus, we propose a theoretical protocol based on previous findings to assess better the effect of LF rTMS for treatment-resistant OCD patients. Methods: We will recruit patients with moderate to severe OCD and limited response to previous treatments from in- and outpatient clinics. We will use fMRI for precious localization of the right dlPFC and application of 1 Hz stimulation of in total 2000 pulses with three times 40 s inter-train intervals 5 days a week, in 6 consecutive weeks. The primary outcome will be the mean reduction in Y-BOCS at the end of this study. Conclusions: This study highlights rTMS’s potential to reform OCD treatment, accentuate safety, accessibility, clinical integration, and future research foundations.
- Open Access
- 25 December 2024
- Published by Springer Nature in Cureus
- Vol. 16 (12) , e76390
Avoidant/Restrictive Food Intake Disorder in a Pediatric Obese Patient
Avoidant/restrictive food intake disorder (ARFID) can present with limited food variety, intake, or aversions. The symptoms can manifest at any age and typically appear in the first few years of life. The prevalence of ARFID varies widely among clinical and non-clinical populations, and its diagnosis requires trained health professionals to ensure early detection and prevention of poor outcomes. A four-year-old boy developed an aversion to solid foods after a choking incident with chicken nuggets, fearing a recurrence. Pre-existing phobias and developmental delays compounded his selective eating. Despite a BMI percentile over the 99th percentile for his age (20.34 kg/m2), ARFID was diagnosed after a psychiatric referral, highlighting the intricate psychological aspect of pediatric feeding disorders. Patients with ARFID may exhibit unexpected weight variations, and nutritional deficiencies do not always appear with low body weight. Child obesity is a pressing US public health issue, affecting 19.7%, potentially leading to psychiatric comorbidities such as depression or anxiety. Health professionals require training to detect and prevent adverse outcomes. Understanding the mechanisms perpetuating ARFID and addressing mental health in this population are crucial aspects of daily practice.
- 25 December 2024
- Published by Springer Nature in Cureus
- Vol. 16 (12) , e76390
Open AccessAvoidant/Restrictive Food Intake Disorder in a Pediatric Obese Patient
Avoidant/restrictive food intake disorder (ARFID) can present with limited food variety, intake, or aversions. The symptoms can manifest at any age and typically appear in the first few years of life. The prevalence of ARFID varies widely among clinical and non-clinical populations, and its diagnosis requires trained health professionals to ensure early detection and prevention of poor outcomes. A four-year-old boy developed an aversion to solid foods after a choking incident with chicken nuggets, fearing a recurrence. Pre-existing phobias and developmental delays compounded his selective eating. Despite a BMI percentile over the 99th percentile for his age (20.34 kg/m2), ARFID was diagnosed after a psychiatric referral, highlighting the intricate psychological aspect of pediatric feeding disorders. Patients with ARFID may exhibit unexpected weight variations, and nutritional deficiencies do not always appear with low body weight. Child obesity is a pressing US public health issue, affecting 19.7%, potentially leading to psychiatric comorbidities such as depression or anxiety. Health professionals require training to detect and prevent adverse outcomes. Understanding the mechanisms perpetuating ARFID and addressing mental health in this population are crucial aspects of daily practice.
- 1 September 2019
- Published by Elsevier in Diabetes & Metabolic Syndrome: Clinical Research & Reviews
- Vol. 13 (5) , 2855-2859
Relationship between body fat percentage and insulin resistance in adults with Bmi values below 25 Kg/M2 in a private clinic
- 1 September 2019
- Published by Elsevier in Diabetes & Metabolic Syndrome: Clinical Research & Reviews
- Vol. 13 (5) , 2855-2859
Relationship between body fat percentage and insulin resistance in adults with Bmi values below 25 Kg/M2 in a private clinic
- Open Access
- 1 February 2018
- Published by Elsevier in Taiwanese Journal of Obstetrics and Gynecology
- Vol. 57 (1) , 175-176
Comment on first trimester maternal serum analytes and second trimester uterine artery doppler in the prediction of preeclampsia and fetal growth restriction
- 1 February 2018
- Published by Elsevier in Taiwanese Journal of Obstetrics and Gynecology
- Vol. 57 (1) , 175-176
Open AccessComment on first trimester maternal serum analytes and second trimester uterine artery doppler in the prediction of preeclampsia and fetal growth restriction